Previous studies have demonstrated in colon cancer and breast cancer cells that SIRT1 localizes at the promoter of ECAD gene and its long-term inhibition via shRNA results in increased histone H4K16-and H3K9-acetylation respectively, which strongly associates with ECAD, TSG re-expression [15]. This evidence concerns the gene CDH1 and breast carcinoma.